These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 7905786)

  • 41. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
    Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G
    Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug resistance mediated by P-glycoproteins.
    Schinkel AH; Borst P
    Semin Cancer Biol; 1991 Aug; 2(4):213-26. PubMed ID: 1680493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
    J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
    Hait WN; Choudhury S; Srimatkandada S; Murren JR
    J Clin Invest; 1993 May; 91(5):2207-15. PubMed ID: 8098047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
    Per SR; Mattern MR; Mirabelli CK; Drake FH; Johnson RK; Crooke ST
    Mol Pharmacol; 1987 Jul; 32(1):17-25. PubMed ID: 3037302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RS-33295-198: a novel, potent modulator of P-glycoprotein-mediated multidrug resistance.
    Slate DL; Bruno NA; Casey SM; Zutshi N; Garvin LJ; Wu H; Pfister JR
    Anticancer Res; 1995; 15(3):811-4. PubMed ID: 7645963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular expression of P-glycoprotein in a human colon tumor cell line.
    Duensing TD; Slate DL
    Anticancer Res; 1994; 14(1A):13-9. PubMed ID: 7513140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between multidrug resistance and tumor necrosis factor resistance in an EL4 cell line model.
    Ujhazy P; Chen YF; Fredericks W; Ho RL; Mihich E; Baker RM; Ehrke MJ
    Cancer Commun; 1990; 2(5):181-8. PubMed ID: 1973358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone).
    Weber JM; Sircar S; Horvath J; Dion P
    Cancer Res; 1989 Nov; 49(21):5779-83. PubMed ID: 2571411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
    Shinoda H; Inaba M; Tsuruo T
    Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
    Mirski SE; Gerlach JH; Cole SP
    Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA-mediated transfer and cloning of a human multidrug-resistant gene of adriamycin-resistant myelogenous leukemia K562.
    Sugimoto Y; Tsuruo T
    Cancer Res; 1987 May; 47(10):2620-5. PubMed ID: 3032411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug resistance studies on intraspecific hybridomas.
    Pályi I; Turi G; Szikla K; Dallmann L
    Arch Geschwulstforsch; 1981; 51(1):119-24. PubMed ID: 7259434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Terfenadine (Seldane): a new drug for restoring sensitivity to multidrug resistant cancer cells.
    Hait WN; Gesmonde JF; Murren JR; Yang JM; Chen HX; Reiss M
    Biochem Pharmacol; 1993 Jan; 45(2):401-6. PubMed ID: 8094615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.